GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
St. Jude Medical, Inc. (STJ) [hlAlert]

Rating:
Overweight
STJ
up 13.81 %

St. Jude Medical, Inc. (STJ) upgraded to Overweight by Morgan Stanley

Posted on: Monday,  Jan 6, 2014  8:25 AM ET by Morgan Stanley

Morgan Stanley rated Overweight St. Jude Medical, Inc. (NYSE: STJ) on 01/06/2014, when the stock price was $63.64.
Since then, St. Jude Medical, Inc. has gained 13.81% as of 01/28/2016's recent price of $72.43.
If you would have followed this Morgan Stanley's recommendation on STJ, you would have gained 13.81% of your investment in 752 days.

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/6/2014 8:25 AM Buy
None
63.64
as of 10/17/2014
1 Week down  -4.12 %
1 Month down  -7.90 %
3 Months down  -12.72 %
1 YTD down  -8.42 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/29/2012 8:25 AM Hold
None
38.29

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy